Navigation Links
Susquehanna Financial Group Hires Gary Nachman as Senior Analyst to Cover the Specialty Pharmaceuticals Sector
Date:7/20/2010

NEW YORK, July 20 /PRNewswire/ -- Susquehanna Financial Group, LLLP (SFG), the institutional broker-dealer member of the Susquehanna International Group of Companies (SIG), announced today that Gary Nachman has joined the firm as the Senior Analyst covering the Specialty Pharmaceuticals sector. Mr. Nachman, whose coverage will include names such as Allergan, Cephalon, Forest Labs, King Pharmaceuticals, Shire Pharmaceuticals and Warner Chilcott, will be based out of SFG's New York office.

"Gary is an exciting addition to SFG's growing Healthcare research team – which consists of A.J. Rice (Healthcare Facilities and Services), Chris Rigg (Managed Care) and David Turkaly (Medical Supplies and Devices)," said Mike Towey, SFG's Director of Research. "The addition of Gary brings us to 23 senior fundamental analyst teams in six major industry sectors (Financial, Consumer, Healthcare, Energy, Industrials, and TMT). Gary's coverage of the Specialty Pharmaceuticals sector is the perfect complement to our healthcare team and will further leverage our healthcare trading efforts, led by Michael Karmiol."

"Gary is a premier analyst in the sector and we are excited to have him join our formidable Healthcare vertical. Gary's research is thoughtful and differentiated and his industry experience was very appealing to us," stated Cory Carlesimo, SFG's Head of Equities. "We think that experience is additive to the investment process for our clients and is why a significant number of the 75+ hires we have made year to date have had either industry or buy-side experience."

For the last five years, Mr. Nachman has worked at Leerink Swann & Co., where he was ranked in the top 5 in the Greenwich Associates survey in Specialty Pharmaceuticals in 2008 and 2009 and #1 in the Institutional Investor's Specialty Pharmaceuticals "Best of the Boutiques" survey from 2005 to 2007. Before joining Leerink, Mr. Nachman spent five years at Morgan Stanley, where he was a member of an equity research team that was top ranked by Institutional Investor and Greenwich Associates. Mr. Nachman's prior experience included three years as a manager in the Financial Evaluations Group of Merck & Co. and as a senior accountant at Ernst & Young. Mr. Nachman earned his MBA from Columbia Business School and his Bachelor of Science degree from the State University of New York at Binghamton.

Mr. Nachman's appointment follows a number of significant U.S. equity research senior analyst hires in the last six months, including:

  • Don Carson - Agricultural, Commodity, and Specialty Chemicals (joins in August)
  • Chris Caso - Semiconductor Devices
  • Ted Grace - Industrials/Machinery
  • Duane Grubert - Exploration & Production
  • David Hilder - Large-Cap Banks
  • Mehdi Hosseini - Semiconductor Capital Equip/Cleantech (joins in August)
  • A.J. Rice - Healthcare Services
  • Rachael Rothman, CFA - Gaming, Lodging, Leisure and Restaurants
  • Bob Summers - Food, Drug and Discounter Retailing
  • Matt Troy – Transportation Services (joins in September)

About Susquehanna Financial Group, LLLP

Susquehanna Financial Group, LLLP (SFG), a member of the Susquehanna International Group of Companies (SIG), is an innovator in global finance, servicing the needs of clients worldwide in the areas of sales, fundamental research, and market intelligence. Building upon SIG's command of the options marketplace and its quantitative trading capabilities, SFG has cultivated a robust service offering that provides liquidity, industry-leading insights, and execution services. SIG employs approximately 1,500 individuals located in North America, Europe, Asia, and Australia. For additional information, please visit www.sig.com.


'/>"/>
SOURCE Susquehanna Financial Group, LLLP
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
2. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
3. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
4. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
5. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
6. Progen Pharmaceuticals Announces Fiscal 2007 Financial Results
7. Biopure Announces 2007 Third Quarter Financial Results
8. Xytis Names Gordon H. Busenbark as Chief Financial Officer
9. Favrille Provides Update on Timing of Analysis from Pivotal Phase 3 Clinical Trial; Reports Third Quarter 2007 Financial Results
10. Pharmacopeia Announces Third Quarter 2007 Financial Results
11. Emisphere Technologies, Inc. Announces 2007 Third Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... 2017  RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("the ... focused on tissue protection, repair and regeneration, today ... Ltd., received a positive response from the U.S. ... for RGN-137 to treat epidermolysis bullosa ("EB"). RGN-137 ... Thymosin beta 4 ("Tß4") as the active pharmaceutical ...
(Date:2/27/2017)... -- Now in its seventh year, the Pharmaceutical ... successful at developing and commercialising innovation. ... The Index can be summarised ... two different companies in early phase, which would make the ... of each company,s performance between 2011 and 2016, the 2017 ranking sees ...
(Date:2/27/2017)... , February 27, 2017 Leading Countries, ... market is expected to grow at a CAGR of 8.9% ... expected to grow at a CAGR of 9.1% from 2016 to ... in 2027. ... this report will benefit you Read on to discover how ...
Breaking Medicine Technology:
(Date:2/26/2017)... ... February 26, 2017 , ... This is ... the world’s first to be ISO/IEC 17025:2005 INAB accredited for Der p 1 ... 17025:2005 is the globally recognised standard that sets out requirements for the technical ...
(Date:2/26/2017)... ... February 26, 2017 , ... ... in North America, today announced it would be offering some it’s exclusive product ... itself on crafting quality and unique baby clothing/feeding products, will team up with ...
(Date:2/26/2017)... ... February 26, 2017 , ... ... and reporting for healthcare organizations. This comprehensive and customizable solution empowers StaffBridge ... StaffBridge technology improves staffing efficiency, maximizes resource allocation, collects critical reporting data, ...
(Date:2/26/2017)... ... February 26, 2017 , ... Functional imaging data supports ... a study released today at the 1st Pan American Parkinson’s and Movement Disorders ... be effective in improving cognitive function in PD patients. This study, led by ...
(Date:2/25/2017)... ... , ... FCPX users now have the ability to sharpen a desired color ... users have total control over sharpening amount, sharpening radius, threshold, horizontal sharpening, vertical sharpening, ... users can visually see the color range effected with ease all within Final ...
Breaking Medicine News(10 mins):